Gordon W. Duncan

8.3k total citations · 2 hit papers
75 papers, 5.7k citations indexed

About

Gordon W. Duncan is a scholar working on Neurology, Cognitive Neuroscience and Epidemiology. According to data from OpenAlex, Gordon W. Duncan has authored 75 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Neurology, 15 papers in Cognitive Neuroscience and 14 papers in Epidemiology. Recurrent topics in Gordon W. Duncan's work include Parkinson's Disease Mechanisms and Treatments (42 papers), Neurological disorders and treatments (20 papers) and Ginkgo biloba and Cashew Applications (11 papers). Gordon W. Duncan is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (42 papers), Neurological disorders and treatments (20 papers) and Ginkgo biloba and Cashew Applications (11 papers). Gordon W. Duncan collaborates with scholars based in United Kingdom, Australia and United States. Gordon W. Duncan's co-authors include David J. Burn, Alison J. Yarnall, Tien K. Khoo, J.P. Mohr, Michael S. Pessin, Roger A. Barker, John T. O’Brien, David J. Brooks, Rachael A. Lawson and R Goldstein and has published in prestigious journals such as New England Journal of Medicine, Brain and Neurology.

In The Last Decade

Gordon W. Duncan

72 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Harvard Cooperative Stroke Registry

1978 846 citations Gordon W. Duncan et al. profile →
Characterizing mild cognitive impairment in incident Parkinson disease

2013 330 citations Alison J. Yarnall, David P. Breen et al. profile →

Peers

Countries citing papers authored by Gordon W. Duncan

Since Specialization

Citations

This map shows the geographic impact of Gordon W. Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon W. Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon W. Duncan more than expected).

Fields of papers citing papers by Gordon W. Duncan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon W. Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon W. Duncan. The network helps show where Gordon W. Duncan may publish in the future.

Co-authorship network of co-authors of Gordon W. Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon W. Duncan. A scholar is included among the top collaborators of Gordon W. Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon W. Duncan. Gordon W. Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration 2025 ·International Journal of Geriatric Psychiatry ·Catherine Pennington, Harriet A. Ball, Peter Connelly, Elizabeth Coulthard, Gordon W. Duncan, Chineze Ivenso, Tobias Langheinrich, (unknown), Terence J. Quinn, (unknown), Karen Ritchie, Tom C. Russ	0
2	Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease 2022 ·Brain ·Nicola J. Ray, Rachael Lawson, Sarah L. Martin, Hilmar P. Sigurdsson, Joanna Wilson, Brook Galna, Sue Lord, Lisa Alcock, Gordon W. Duncan, Tien K. Khoo, John T. O’Brien, David J. Burn, John‐Paul Taylor, (unknown), Maurizio Bergamino, Lynn Rochester, Alison J. Yarnall	23
3	Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort 2021 ·Journal of Parkinson s Disease ·Rachael A. Lawson, (unknown), Caroline H. Williams‐Gray, Marta Camacho, Gordon W. Duncan, Tien K. Khoo, David P. Breen, Roger A. Barker, Lynn Rochester, David J. Burn, Alison J. Yarnall	21
4	Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease 2019 ·Journal of Parkinson s Disease ·Isobel Sleeman, Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, (unknown), Tien K. Khoo, David J. Burn	35
5	Pro‐Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE‐PD 2019 ·Movement Disorders ·Samuel Stuart, Rachael A. Lawson, Alison J. Yarnall, Jeremy Nell, Lisa Alcock, Gordon W. Duncan, Tien K. Khoo, Roger A. Barker, Lynn Rochester, David J. Burn, (unknown)	35
6	Longitudinal diffusion tensor imaging changes in early Parkinson’s disease: ICICLE-PD study 2018 ·Journal of Neurology ·Thaı́s Minett, Li Su, Elijah Mak, Guy Williams, Michael Firbank, Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, Adrian M. Owen, Tien K. Khoo, David J. Brooks, James B. Rowe, Roger A. Barker, David J. Burn, John T. O’Brien	39
7	The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease 2017 ·Journal of Parkinson s Disease ·Isobel Sleeman, Terry Aspray, Rachael A. Lawson, Shirley Coleman, Gordon W. Duncan, Tien K. Khoo, Inez Schoenmakers, Lynn Rochester, David J. Burn, Alison J. Yarnall	58
8	Stability of mild cognitive impairment in newly diagnosed Parkinson's disease 2017 ·Journal of Neurology Neurosurgery & Psychiatry ·Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, David P. Breen, Tien K. Khoo, Caroline H. Williams‐Gray, Roger A. Barker, David J. Burn	64
9	Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease 2017 ·Parkinsonism & Related Disorders ·N. Dissanayaka, Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, David P. Breen, Tien K. Khoo, Roger A. Barker, David J. Burn	57
10	Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease 2017 ·Neurobiology of Aging ·Elijah Mak, Li Su, Guy Williams, Michael Firbank, Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, Brit Mollenhauer, Adrian M. Owen, Tien K. Khoo, David J. Brooks, James B. Rowe, Roger A. Barker, David J. Burn, John T. O’Brien	54
11	Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study 2016 ·Journal of Neurology Neurosurgery & Psychiatry ·Michael Firbank, Alison J. Yarnall, Rachael A. Lawson, Gordon W. Duncan, Tien K. Khoo, George Petrides, John T. O’Brien, Roger A. Barker, R. J. Maxwell, David J. Brooks, David J. Burn	88
12	Quality of Life and Mild Cognitive Impairment in Early Parkinson’s Disease: Does Subtype Matter? 2015 ·Journal of Parkinson s Disease ·Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, Tien K. Khoo, David P. Breen, Roger A. Barker, Daniel Collerton, John‐Paul Taylor, David J. Burn	25
13	Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study 2014 ·Brain ·Cristina Nombela, James B. Rowe, Sophie Winder‐Rhodes, Adam Hampshire, Adrian M. Owen, David P. Breen, Gordon W. Duncan, Tien K. Khoo, Alison J. Yarnall, Michael Firbank, Patrick F. Chinnery, Trevor W. Robbins, John T. O’Brien, David J. Brooks, David J. Burn, Roger A. Barker	127
14	Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life 2014 ·Parkinsonism & Related Disorders ·Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, Tien K. Khoo, David P. Breen, Roger A. Barker, Daniel Collerton, John‐Paul Taylor, David J. Burn	115
15	The incidence of Parkinson's disease in the North-East of England 2013 ·Age and Ageing ·Gordon W. Duncan, Tien K. Khoo, Shirley Coleman, Carol Brayne, Alison J. Yarnall, John T. O’Brien, Roger A. Barker, David J. Burn	26
16	Depression and anxiety in incident Parkinson’s disease 2012 ·(unknown), David J. Burn, Tien K. Khoo, Alison J. Yarnall, Gordon W. Duncan, David J. Brooks, Roger A. Barker	0
17	The Aging Brain and Neurodegenerative Diseases 2011 ·Clinics in Geriatric Medicine ·Gordon W. Duncan	21
18	Vasovagal syncope in the older person: differences in presentation between older and younger patients 2010 ·Age and Ageing ·Gordon W. Duncan, Maw Pin Tan, Julia L. Newton, (unknown), Steve W. Parry	32
19	Perinatal and maternal risk factors for autism spectrum disorders in New South Wales, Australia 2008 ·Child Care Health and Development ·Katrina Williams, (unknown), Gordon W. Duncan, Jennifer Peat, Craig M. Mellis	76
20	Termination of pregnancy: Lessons for prevention 1990 ·Oxford University Research Archive (ORA) (University of Oxford) ·Gordon W. Duncan, (unknown), (unknown), David Mant, Heather Buchan, Laura Jones	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact